GLENMARK PHARMACEUTICALS
Back to All Ratios
|
GLENMARK PHARMACEUTICALS Last 5 Year Return on Equity (ROE) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| ROE(%) | 14.10 | 12.56 | -21.18 | -0.97 | 12.33 |
What is the latest Return on Equity (ROE) ratio of GLENMARK PHARMACEUTICALS ?
| Year | Return on Equity (ROE) |
|---|---|
| Mar2026 | 14.10 |
| Mar2025 | 12.56 |
| Mar2024 | -21.18 |
| Mar2023 | -0.97 |
| Mar2022 | 12.33 |
How is Return on Equity (ROE) of GLENMARK PHARMACEUTICALS Trending?
| Years | Return on Equity (ROE) | % Change | |
|---|---|---|---|
| Mar2026 | 14.1 | 12.26 | |
| Mar2025 | 12.56 | Positive | |
| Mar2024 | -21.18 | Negative | |
| Mar2023 | -0.97 | Negative | |
| Mar2022 | 12.33 | - | |
Other Financial Ratios of GLENMARK PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Return on Equity (ROE) ratio of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹70,263.6 Cr | 4% | 11.5% | 28.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,310.0 Cr | 2% | -1.7% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,426.0 Cr | 6.5% | 14.8% | 48.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,347.0 Cr | 1.2% | -2.5% | 37.2% | Stock Analytics | |
| CIPLA | ₹114,393.0 Cr | -0.3% | -3.9% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,240.2 Cr | -2.2% | 1.5% | -8.3% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 4% |
11.5% |
28.7% |
| SENSEX | -0.5% |
-1.3% |
-5.4% |
You may also like the below Video Courses